Cargando…
The agonistic TSPO ligand XBD173 attenuates the glial response thereby protecting inner retinal neurons in a murine model of retinal ischemia
BACKGROUND: Ligand-driven modulation of the mitochondrial translocator protein 18 kDa (TSPO) was recently described to dampen the neuroinflammatory response of microglia in a retinal light damage model resulting in protective effects on photoreceptors. We characterized the effects of the TSPO ligand...
Autores principales: | Mages, Kristin, Grassmann, Felix, Jägle, Herbert, Rupprecht, Rainer, Weber, Bernhard H. F., Hauck, Stefanie M., Grosche, Antje |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378755/ https://www.ncbi.nlm.nih.gov/pubmed/30777091 http://dx.doi.org/10.1186/s12974-019-1424-5 |
Ejemplares similares
-
Chronic administration of XBD173 ameliorates cognitive deficits and neuropathology via 18 kDa translocator protein (TSPO) in a mouse model of Alzheimer’s disease
por: Pradhan, Arpit Kumar, et al.
Publicado: (2023) -
Suppression of SNARE‐dependent exocytosis in retinal glial cells and its effect on ischemia‐induced neurodegeneration
por: Wagner, Lysann, et al.
Publicado: (2017) -
Human pharmacokinetics of XBD173 and etifoxine distinguish their potential for pharmacodynamic effects mediated by translocator protein
por: Owen, David R., et al.
Publicado: (2022) -
GABA and Glutamate Uptake and Metabolism in Retinal Glial (Müller) Cells
por: Bringmann, Andreas, et al.
Publicado: (2013) -
Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis
por: Karlstetter, Marcus, et al.
Publicado: (2014)